Author Altincatal, Arman
Santagostino, Elena
Sidonio, Robert F.
Katragadda, Suresh
Casiano, Sandra
Falk, Aletta
Windyga, Jerzy
Author_xml – sequence: 1
  givenname: Robert F.
  surname: Sidonio
  fullname: Sidonio, Robert F.
  email: robert.sidonio.jr@emory.edu
  organization: Emory University School of Medicine
– sequence: 2
  givenname: Sandra
  surname: Casiano
  fullname: Casiano, Sandra
  organization: Sanofi
– sequence: 3
  givenname: Aletta
  surname: Falk
  fullname: Falk, Aletta
  organization: Swedish Orphan Biovitrum AB
– sequence: 4
  givenname: Arman
  surname: Altincatal
  fullname: Altincatal, Arman
  organization: Sanofi
– sequence: 5
  givenname: Suresh
  surname: Katragadda
  fullname: Katragadda, Suresh
  organization: Sanofi
– sequence: 6
  givenname: Elena
  surname: Santagostino
  fullname: Santagostino, Elena
  organization: Swedish Orphan Biovitrum AG
– sequence: 7
  givenname: Jerzy
  orcidid: 0000-0001-7877-4784
  surname: Windyga
  fullname: Windyga, Jerzy
  organization: Institute of Hematology and Transfusion Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36548200$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtuFDEURS0URD4wYAPIEhMyqMR2tctVwxDlJ7UIA5CYWa_cz7SbKruxXaCeZQksgbWxEhy6I6EIPLEH51w9v3tI9nzwSMhLzk54OadLwBM-U0I9IQe8bmQlJG_27t-SV63gzT45TGnFGK8Fa56R_cLMWsHYAfn5fglxBBO-OI_ZGbqGCCNmjIkGSyOaMPbOg8_Ugskh0ptP9NJQOyUXPF3HkNF5ChGpD5k6b4cJvcEF7Td_GcV3n9HTAb_hkApG09Sv0OREbQwjzUukZZKEtKZvf939mN--u6I5Ohiek6cWhoQvdvcR-Xh58eH8uprfXt2cn80rU7etqqCxzCjb8ZbBQnJZKyOlgKZFIzuwrZTQtxxnDEB1gKZfyKYVPaCAbmYEq4_Im21u-dLXCVPWo0sGhwE8hilpoaRisqmZKujrR-gqTNGX6QrVtFx0UtWFerWjpn7EhV5HN0Lc6IfdF-B0C5gYUopotXEZcllrjuAGzZm-b1eXdvWfdotx_Mh4CP0Xu0v_7gbc_B_U12cXW-M3Y8207Q
CitedBy_id crossref_primary_10_1111_ejh_14176
crossref_primary_10_1111_hae_14999
crossref_primary_10_1007_s40265_023_01868_7
Cites_doi 10.1182/blood.2018884015
10.1111/hae.14046
10.1073/pnas.93.20.11068
10.1111/hae.14300
10.1056/NEJMoa1305074
10.1182/bloodadvances.2016002923
10.1021/bi00121a031
10.1182/blood-2009-08-239665
ContentType Journal Article
Copyright 2022 John Wiley & Sons Ltd.
2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 John Wiley & Sons Ltd.
– notice: 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1111/hae.14727
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2516
EndPage 407
ExternalDocumentID 36548200
10_1111_hae_14727
HAE14727
Genre letter
Letter
Clinical Trial, Phase III
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29I
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EGARE
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3887-a6f0c7f9180ad51537c552a68ec59af855ab81e40aa79aecbd5682bae2a94c203
IEDL.DBID DR2
ISSN 1351-8216
1365-2516
IngestDate Thu Jul 10 22:25:09 EDT 2025
Fri Jul 25 09:52:30 EDT 2025
Wed Feb 19 02:23:49 EST 2025
Tue Jul 01 03:04:29 EDT 2025
Thu Apr 24 23:12:23 EDT 2025
Wed Jan 22 16:18:11 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords clinical study
pharmacokinetics
factor IX
haemophilia B
factor IX Fc fusion protein
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3887-a6f0c7f9180ad51537c552a68ec59af855ab81e40aa79aecbd5682bae2a94c203
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Correspondence-3
content type line 23
ORCID 0000-0001-7877-4784
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hae.14727
PMID 36548200
PQID 2768129573
PQPubID 2045152
PageCount 4
ParticipantIDs proquest_miscellaneous_2757056307
proquest_journals_2768129573
pubmed_primary_36548200
crossref_citationtrail_10_1111_hae_14727
crossref_primary_10_1111_hae_14727
wiley_primary_10_1111_hae_14727_HAE14727
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2023
2023-01-00
2023-Jan
20230101
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: January 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle Haemophilia : the official journal of the World Federation of Hemophilia
PublicationTitleAlternate Haemophilia
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_1_6_7_1
e_1_2_1_6_6_1
e_1_2_1_6_9_1
e_1_2_1_6_8_1
e_1_2_1_6_3_1
e_1_2_1_6_2_1
e_1_2_1_6_5_1
e_1_2_1_6_4_1
References_xml – ident: e_1_2_1_6_6_1
  doi: 10.1182/blood.2018884015
– ident: e_1_2_1_6_2_1
  doi: 10.1111/hae.14046
– ident: e_1_2_1_6_4_1
  doi: 10.1073/pnas.93.20.11068
– ident: e_1_2_1_6_7_1
  doi: 10.1111/hae.14300
– ident: e_1_2_1_6_9_1
  doi: 10.1056/NEJMoa1305074
– ident: e_1_2_1_6_3_1
  doi: 10.1182/bloodadvances.2016002923
– ident: e_1_2_1_6_5_1
  doi: 10.1021/bi00121a031
– ident: e_1_2_1_6_8_1
  doi: 10.1182/blood-2009-08-239665
SSID ssj0013206
Score 2.3782518
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 404
SubjectTerms clinical study
Coagulation factors
factor IX
Factor IX - pharmacokinetics
Factor IX - therapeutic use
factor IX Fc fusion protein
Fc receptors
Fusion protein
haemophilia B
Hemophilia B - drug therapy
Humans
Immunoglobulin Fc Fragments - therapeutic use
Pharmacokinetics
Recombinant Fusion Proteins - pharmacokinetics
Recombinant Fusion Proteins - therapeutic use
Title Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhae.14727
https://www.ncbi.nlm.nih.gov/pubmed/36548200
https://www.proquest.com/docview/2768129573
https://www.proquest.com/docview/2757056307
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIiEuUJ5dWqoBceCSynnYSdTTbumyIFoQotIekCLbsUXVNouazYGe-An8BH4bv6QzzkNbHhLilijj2HFm7M_j8TeMPc8QZAhnbaC0dEGSZiLIQh4HpcsEAuJccX987PBIzo6TN3MxX2N7_VmYlh9icLiRZfjxmgxc6XrFyD8ri2aO0y-OvxSrRYDoQ7Syg-DzalICuiCLQtmxClEUz1Dy-lz0G8C8jlf9hDO9wz71TW3jTE53m6XeNZe_sDj-57dssNsdEIVxqzl32Zqt7rGbh91W-332431Han2KtygDRBJ-TsEzNSwc0EL6XPswGmhz9sDrOUwNuIb8b-D5H04qUBcWqsUSTvpkKCXoryslsDzxgcIZBS_VKAZ1o8k3VAOdfAHEp4AtqS3EMPn57fvbd0evwKcaecCOpwcf92dBl84hMDENZUo6blKXhxlXJcKoODVCREpm1ohckW4onYU24UqlubJGl0JmkVY2UnliIh4_ZOvVorKbDHDVpUPJFXelTbSLVGg1McunkmsjEzdiL_ofW5iO65xSbpwV_ZoHe7zwPT5izwbRLy3Bx5-EtnvtKDobr4soJe62XKTxiD0dHqN10paLquyiIRmRcqJgw1c8arVqqAV1NkH8xbGxXjf-Xn0xGx_4i8f_LrrFbkWIx1pv0TZbX1409gnip6XeYTfGk5eT6Y43mCvhLBhJ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL78JCgQFx4JLKedhJJC4FddnC7oJQK-0FRbZji6ptFjWbA5z4CfwEfhu_hBnnoS0PCXFLlHHiJDP2N-PxN4w9zRBkCGdtoLR0QZJmIshCHgelywQC4lxxv31sNpeTw-T1Qiw22PN-L0zLDzEE3Mgy_HhNBk4B6TUr_6gs2jnOvxfYRaro7R2q99HaGoKvrEkl6IIsCmXHK0R5PEPT87PRbxDzPGL1U874GvvQd7bNNDneaVZ6x3z5hcfxf9_mOrvaYVHYbZXnBtuw1U12adattt9i3991vNbHeIoyQDzhp5Q_U8PSAfnSp9pn0kBbtgf2FzA24BoKwYGngDiqQJ1ZqJYrOOrroZSgP6-1wPZECQonlL9UoxjUjabwUA20-QUQogL2pLYQw4sfX79N385fga82cpsdjvcOXk6CrqJDYGIazZR03KQuDzOuSkRScWqEiJTMrBG5IvVQOgttwpVKc2WNLoXMIq1spPLERDzeYpvVsrJ3GaDjpUPJFXelTbSLVGg1kcunkmsjEzdiz_o_W5iO7pyqbpwUvduDX7zwX3zEngyin1qOjz8JbffqUXRmXhdRSvRtuUjjEXs8XEYDpVUXVdllQzIi5cTChre406rV8JRYosOI4xR21ivH3x9fTHb3_MG9fxd9xC5PDmbTYro_f3OfXYkQnrXBo222uTpr7AOEUyv90FvNT3iVGvI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkSoulDdbCgyIA5dUzsNOIk6FdtlCu1SISntAimzHFlXbbNVsDnDiJ_AT-G38Emach7Y8JMQtUcax48zYn8fjbxh7liHIEM7aQGnpgiTNRJCFPA5KlwkExLni_vjYwVROjpI3MzFbYS_6szAtP8TgcCPL8OM1Gfh56ZaM_JOyaOY4_V5hVxPJM1LpnffR0haCT6xJGeiCLAplRytEYTxD0cuT0W8I8zJg9TPOeJ197NvaBpqcbDULvWW-_ELj-J8fc4Nd75AobLeqc5Ot2OoWWzvo9tpvs--HHav1Cd6iDBBL-BlFz9Qwd0Ar6TPt42igTdoDezMYG3ANOeDAE0AcV6AuLFTzBRz32VBK0J-XSmB5IgSFU4peqlEM6kaTc6gGOvoCCFABW1JbiOHlj6_f9t9NX4PPNXKHHY13P7yaBF0-h8DENJYp6bhJXR5mXJWIo-LUCBEpmVkjckXKoXQW2oQrlebKGl0KmUVa2UjliYl4fJetVvPK3meAyy4dSq64K22iXaRCq4laPpVcG5m4EXve_9jCdGTnlHPjtOgXPdjjhe_xEXs6iJ63DB9_EtrstaPojLwuopTI23KRxiP2ZHiM5kl7Lqqy84ZkRMqJgw1fca_VqqGWWOJyEUcpbKzXjb9XX0y2d_3Fxr-LPmZrhzvjYn9v-vYBuxYhNms9R5tsdXHR2IeIpRb6kbeZnzZOGao
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetic+parameters+of+recombinant+factor+IX+Fc+fusion+protein+are+not+influenced+by+factor+IX+antigen+levels+in+subjects+from+the+Phase+3+B-LONG+trial&rft.jtitle=Haemophilia+%3A+the+official+journal+of+the+World+Federation+of+Hemophilia&rft.au=Sidonio%2C+Robert+F&rft.au=Casiano%2C+Sandra&rft.au=Falk%2C+Aletta&rft.au=Altincatal%2C+Arman&rft.date=2023-01-01&rft.issn=1365-2516&rft.eissn=1365-2516&rft.volume=29&rft.issue=1&rft.spage=404&rft_id=info:doi/10.1111%2Fhae.14727&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-8216&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-8216&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-8216&client=summon